Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Suanfarma CDMO offers integrated end-to-end solutions for development & commercialization of intermediates & APIs for small molecules.

    Virtual Booth

    Contact Supplier

    dmfs-not-supported-m-2025-06-30

    Virtual Booth

    An Enquiry

    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    veranova-m-2025-06-30

    Virtual Booth

    Contact Supplier

    jdmfs-not-supported-m-2025-06-30

    Virtual Booth

    An Enquiry

    Menu

    Psilocybine

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    DIGITAL CONTENT

    MARKET PLACE

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Compass Pathways' Depression Drug Meets Main Goal in Late-Stage
    Compass Pathways' Depression Drug Meets Main Goal in Late-Stage

    23 Jun 2025

    // REUTERS

    https://www.reuters.com/business/healthcare-pharmaceuticals/compass-pathways-depression-drug-succeeds-late-stage-trial-2025-06-23/

    REUTERS
    23 Jun 2025
    Share Share
    Rose Hill Inks Export Deal for Psilocybin Supply to Brazil
    Rose Hill Inks Export Deal for Psilocybin Supply to Brazil

    13 Jun 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/06/13/3098998/0/en/Rose-Hill-Apothecary-Executes-First-Major-International-Export-Deal-Supplying-Research-Grade-Psilocybin-to-Brazil.html

    GLOBENEWSWIRE
    13 Jun 2025
    Share Share
    Compass Pathways Completes Dosing for Phase 3 COMP360 Trial
    Compass Pathways Completes Dosing for Phase 3 COMP360 Trial

    22 Apr 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250422821349/en/Compass-Pathways-Announces-Dosing-Complete-for-All-Participants-in-Part-A-of-Phase-3-COMP005-Trial-of-COMP360-Psilocybin-for-Treatment-Resistant-Depression

    BUSINESSWIRE
    22 Apr 2025
    Share Share
    Mikart Supports Cannabinoid & Psilocybin Drug Development
    Mikart Supports Cannabinoid & Psilocybin Drug Development

    18 Apr 2025

    // PRESS RELEASE

    https://www.mikart.com/navigating-emerging-therapeutics-how-mikart-supports-cannabinoid-and-psilocybin-drug-development/

    PRESS RELEASE
    18 Apr 2025
    Share Share
    Bionic Bloom: Cannadelic Miami 2025 Features Laura Hartman
    Bionic Bloom: Cannadelic Miami 2025 Features Laura Hartman

    09 Apr 2025

    // ACCESSWIRE

    https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/bionic-bloom-presents-cannadelic-miami-2025-announces-featured-speake-1012524

    ACCESSWIRE
    09 Apr 2025
    Share Share
    Bionic Bloom Presents: Cannadelic Miami 2025
    Bionic Bloom Presents: Cannadelic Miami 2025

    08 Apr 2025

    // ACCESSWIRE

    https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/bionic-bloom-presents-cannadelic-miami-2025-1012505

    ACCESSWIRE
    08 Apr 2025
    Share Share